Tudor Investment Corp’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-142,555
Closed -$1.28M 1808
2016
Q3
$1.28M Buy
142,555
+34,269
+32% +$244K 0.03% 313
2016
Q2
$581K Sell
108,286
-10,770
-9% -$55.2K 0.01% 737
2016
Q1
$548K Sell
119,056
-66,226
-36% -$266K 0.01% 881
2015
Q4
$963K Sell
185,282
-37,901
-17% -$220K 0.03% 476
2015
Q3
$1.35M Buy
223,183
+191,201
+598% +$2.34M 0.05% 288
2015
Q2
$505K Buy
+31,982
New +$388K 0.01% 773
2014
Q1
Sell
-12,049
Closed -$157K 1631
2013
Q4
$157K Buy
+12,049
New +$166K 0.01% 1144

Tudor Investment Corp's RPTP Position: Q4 2016 in Review

Tudor Investment Corp sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 142,555 shares — an estimated $1.28M sold.

Tudor Investment Corp first reported a position in RPTP in Q4 2013 and held it in 7 quarters. The position peaked at $1.35M in Q3 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Tudor Investment Corp reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Tudor Investment Corp sold 142,555 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $1.28M.
  • Tudor Investment Corp first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2013 and held it in 7 quarters.
  • Tudor Investment Corp's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.35M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Tudor Investment Corp's 13F filing for Q4 2016, filed 14 Feb 2017.